➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Harvard Business School
McKesson
Johnson and Johnson
McKinsey

Last Updated: October 16, 2021

DrugPatentWatch Database Preview

Litigation Details for Teva Pharmaceuticals International GmbH v. Eli Lilly and Company (D. Mass. 2017)


Email this page to a colleague

« Back to Dashboard

Biologic Drugs cited in Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
The biologic drug covered by the patent cited in this case is ⤷  Free Forever Trial .

Details for Teva Pharmaceuticals International GmbH v. Eli Lilly and Company (D. Mass. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-10-24 1 least U.S. Patent Nos. 8,586,045; 8,597,649; 9,266,951; 9,340,614; and 9,346,881 (“the Patents-in-Suit”… THE PATENTS-IN-SUIT A. U.S. Patent No. 8,586,045 38. On November…November 19, 2013, United States Patent No. 8,586,045 (“the ’045 patent”), titled “Methods of Using Anti-CGRP…Infringes The Patents-in-Suit. 21. Eli Lilly tracks and follows Teva’s patents related to the… are United States patents in the same family as EP 1957106, including the Patents-in-Suit. EP 1957106 External link to document
2018-09-27 42 Memorandum & Order infringement of five of the Teva Patents, U.S. Patent Nos. 8,586,045; 8,597,649; 9,266,951; 9,340,614;… Trademark Office (“USPTO”) issued U.S. Patent No. 8,586,045, entitled “Methods of Using Anti-CGRP Antagonist…infringement of those patents, in connection with two of the Teva Patents, U.S. Patent Nos. 9,884,907 and…claimed in a patent or the use of which is claimed in a patent before the expiration of such patent.”). As …several patents that are relevant to this dispute. On November 19, 2013, the United States Patent and Trademark External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Baxter
Johnson and Johnson
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.